by Adam | Dec 31, 2020 | News
PROVIDENCE, R.I., Dec. 31, 2020 /PRNewswire/ — EpiVax (“EpiVax”) and EpiVax Therapeutics (“EVT”) today provide an update on the advancement of their peptide-based COVID-19 vaccine, EPV-CoV-19. EPV-CoV-19, a T cell epitope-based vaccine...
by Adam | Apr 15, 2020 | News
Originally published via PR Newswire GOLDEN, Colo., April 14, 2020 /PRNewswire/ — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine...
by Adam | Apr 7, 2020 | News
PROVIDENCE, RI, April 7, 2020 /PRNewswire/ — EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with...
